Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Xiong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1799-2654; OpenAlex author ID A5100770690. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Curcumin Derivative C66 Suppresses Pancreatic Cancer Progression through the Inhibition of JNK-Mediated Inflammation. Co-author DOI 10.3390/molecules27103076↗
  2. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Co-author DOI 10.1007/s12253-010-9307-1↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongjin Chen · 1 shared paper, 2022 · strength 0.16
  2. Qinbo Chen · 1 shared paper, 2022 · strength 0.16
  3. Guang Liang · 1 shared paper, 2022 · strength 0.16
  4. Zheng Xu · 1 shared paper, 2022 · strength 0.16
  5. Yebin Lu · 1 shared paper, 2011 · strength 0.03
  6. Xiaohui Duan · 1 shared paper, 2011 · strength 0.03
  7. Weijia Sun · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.